Russia-Ukraine war live: Ukrainian military says it shot down 20 of 31 drones launched by Russia overnight
EU should spare carmakers from ‘punitive’ emissions fines, says Scholz
Albania bans TikTok for a year after fatal stabbing of teenager last month
Will Japan’s close ties with US survive the caprice and quirks of Donald Trump?
News Corp and Telstra agree sale of Foxtel to sports streaming service DAZN for $3.4bn
Nice says more evidence needed on effectiveness of tirzepatide, sold under brand name Mounjaro
A weight-loss jab has been rejected for NHS use by England’s drugs watchdog.
The National Institute for Health and Care Excellence (Nice), which provides recommendations and guidance to health practitioners, said further evidence was needed on the clinical and cost-effectiveness of tirzepatide, which is sold under the brand name Mounjaro, before it could be recommended for NHS use.
More Stories
‘Wild west’: experts concerned by illegal promotion of weight-loss jabs in UK
Esports are booming in Africa – but can its infrastructure keep pace?
Shrinking waistlines and growing profits: the weight-loss drug boom